NO953254L - Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter - Google Patents
Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakterInfo
- Publication number
- NO953254L NO953254L NO953254A NO953254A NO953254L NO 953254 L NO953254 L NO 953254L NO 953254 A NO953254 A NO 953254A NO 953254 A NO953254 A NO 953254A NO 953254 L NO953254 L NO 953254L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- substituted
- halo
- trifluoromethyl
- alkoxy
- Prior art date
Links
- 241000589989 Helicobacter Species 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- VIXWGKYSYIBATJ-UHFFFAOYSA-N pyrrol-2-one Chemical class O=C1C=CC=N1 VIXWGKYSYIBATJ-UHFFFAOYSA-N 0.000 title 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000001475 halogen functional group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 101100482220 Sulfurisphaera tokodaii (strain DSM 16993 / JCM 10545 / NBRC 100140 / 7) triC gene Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- -1 nitro, amino Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP93200474 | 1993-02-19 | ||
| PCT/EP1994/000380 WO1994018978A1 (en) | 1993-02-19 | 1994-02-09 | Substituted azolone derivatives for treating diseases caused by helicobacter |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO953254D0 NO953254D0 (no) | 1995-08-18 |
| NO953254L true NO953254L (no) | 1995-09-11 |
Family
ID=8213653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO953254A NO953254L (no) | 1993-02-19 | 1995-08-18 | Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5650411A (ru) |
| EP (1) | EP0684821A1 (ru) |
| JP (1) | JPH08506821A (ru) |
| CN (1) | CN1118138A (ru) |
| AP (1) | AP435A (ru) |
| AU (1) | AU675508B2 (ru) |
| CA (1) | CA2155830A1 (ru) |
| FI (1) | FI953899A0 (ru) |
| HU (1) | HUT73662A (ru) |
| IL (1) | IL108703A (ru) |
| LT (1) | LT3214B (ru) |
| MX (1) | MX9401294A (ru) |
| NO (1) | NO953254L (ru) |
| NZ (1) | NZ261854A (ru) |
| PL (1) | PL174836B1 (ru) |
| RU (1) | RU2128659C1 (ru) |
| TW (1) | TW279864B (ru) |
| WO (1) | WO1994018978A1 (ru) |
| ZA (1) | ZA941137B (ru) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5703236A (en) * | 1993-12-21 | 1997-12-30 | Schering Corporation | Tetrahydrofuran antifungals |
| NZ283346A (en) * | 1994-04-06 | 1997-05-26 | Janssen Pharmaceutica Nv | Ester and carbamate derivatives of di- and tri-azolones; medicaments; intermediates |
| US5637592A (en) * | 1994-07-12 | 1997-06-10 | Janssen Pharmaceutica N.V. | Acyl derivatives of azolones |
| US5639754A (en) * | 1994-07-12 | 1997-06-17 | Janssen Pharmaceutica N.V. | Urea and thiourea derivatives of azolones |
| US5607932A (en) * | 1994-07-12 | 1997-03-04 | Janssen Pharmaceutica N.V. | Heterocyclic derivatives of azolones |
| CA2160423A1 (en) * | 1994-11-02 | 1996-05-03 | Hemant N. Joshi | Salts of nefazodone having improved dissolution rates |
| GB9524754D0 (en) * | 1995-12-04 | 1996-04-24 | Symmetricom Inc | Mobile position determination |
| WO1999021834A1 (en) * | 1997-10-27 | 1999-05-06 | Neurosearch A/S | Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors |
| US6268385B1 (en) | 1999-08-26 | 2001-07-31 | Robert R. Whittle | Dry blend pharmaceutical formulations |
| US6262085B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| US6369087B1 (en) | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| US6312712B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Method of improving bioavailability |
| US6316020B1 (en) | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
| US6312723B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Pharmaceutical unit dosage form |
| US6780880B1 (en) | 1999-08-26 | 2004-08-24 | Robert R. Whittle | FT-Raman spectroscopic measurement |
| US6326384B1 (en) | 1999-08-26 | 2001-12-04 | Robert R. Whittle | Dry blend pharmaceutical unit dosage form |
| US6262086B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Pharmaceutical unit dosage form |
| US8013156B2 (en) * | 2003-03-19 | 2011-09-06 | Exelixis, Inc. | Tie-2 modulators and methods of use |
| EP2474525B1 (en) * | 2006-12-26 | 2020-04-15 | Lantheus Medical Imaging, Inc. | Ligands for imaging cardiac innervation |
| CN102234267A (zh) * | 2010-04-21 | 2011-11-09 | 中国科学院上海药物研究所 | 新型三氮唑类抗真菌化合物、其药物组合物及其制备方法和用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4724239A (en) * | 1985-09-16 | 1988-02-09 | Morgan Lee R | Method of treating chemical ulcers with N,N'-diacetylcystine, N-acetyl homocysteine and N-acetyl cysteine |
| CA1292472C (en) * | 1985-12-03 | 1991-11-26 | Alfonsus Guilielmus Knaeps | Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles |
| US4791111A (en) * | 1985-12-23 | 1988-12-13 | Janssen Pharmaceutica, N.V. | [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties |
| CA1331757C (en) * | 1988-02-29 | 1994-08-30 | Janssen Pharmaceutica Naamloze Vennootschap | 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols |
| CA2076257A1 (en) * | 1991-09-13 | 1993-03-14 | Jan Heeres | 4-¬4-¬4-(4-hydroxyphenyl)-1- piperazinyl|phenyl|-5-methyl-3h -1,2,4-triazol-3-one derivatives |
-
1994
- 1994-02-02 TW TW083100854A patent/TW279864B/zh active
- 1994-02-09 PL PL94310348A patent/PL174836B1/pl unknown
- 1994-02-09 CN CN94191221A patent/CN1118138A/zh active Pending
- 1994-02-09 AU AU61081/94A patent/AU675508B2/en not_active Ceased
- 1994-02-09 HU HU9501923A patent/HUT73662A/hu unknown
- 1994-02-09 US US08/491,960 patent/US5650411A/en not_active Expired - Fee Related
- 1994-02-09 JP JP6518613A patent/JPH08506821A/ja active Pending
- 1994-02-09 EP EP94907534A patent/EP0684821A1/en not_active Withdrawn
- 1994-02-09 RU RU95122796A patent/RU2128659C1/ru active
- 1994-02-09 NZ NZ261854A patent/NZ261854A/en unknown
- 1994-02-09 CA CA002155830A patent/CA2155830A1/en not_active Abandoned
- 1994-02-09 WO PCT/EP1994/000380 patent/WO1994018978A1/en not_active Application Discontinuation
- 1994-02-18 MX MX9401294A patent/MX9401294A/es unknown
- 1994-02-18 IL IL108703A patent/IL108703A/en not_active IP Right Cessation
- 1994-02-18 AP APAP/P/1994/000622A patent/AP435A/en active
- 1994-02-18 ZA ZA941137A patent/ZA941137B/xx unknown
- 1994-02-18 LT LTIP1874A patent/LT3214B/lt not_active IP Right Cessation
-
1995
- 1995-08-18 FI FI953899A patent/FI953899A0/fi unknown
- 1995-08-18 NO NO953254A patent/NO953254L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH08506821A (ja) | 1996-07-23 |
| AU675508B2 (en) | 1997-02-06 |
| WO1994018978A1 (en) | 1994-09-01 |
| ZA941137B (en) | 1995-10-25 |
| IL108703A (en) | 1998-01-04 |
| CN1118138A (zh) | 1996-03-06 |
| LT3214B (en) | 1995-04-25 |
| PL174836B1 (pl) | 1998-09-30 |
| AP9400622A0 (en) | 1994-04-30 |
| HUT73662A (en) | 1996-09-30 |
| NZ261854A (en) | 1997-04-24 |
| LTIP1874A (en) | 1994-09-25 |
| CA2155830A1 (en) | 1994-09-01 |
| TW279864B (ru) | 1996-07-01 |
| PL310348A1 (en) | 1995-12-11 |
| NO953254D0 (no) | 1995-08-18 |
| IL108703A0 (en) | 1994-05-30 |
| HU9501923D0 (en) | 1995-09-28 |
| FI953899A (fi) | 1995-08-18 |
| EP0684821A1 (en) | 1995-12-06 |
| MX9401294A (es) | 1994-08-31 |
| US5650411A (en) | 1997-07-22 |
| FI953899A0 (fi) | 1995-08-18 |
| RU2128659C1 (ru) | 1999-04-10 |
| AP435A (en) | 1995-11-17 |
| AU6108194A (en) | 1994-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO953254L (no) | Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter | |
| MX9700340A (es) | Agentes anti-helicobacter derivados sulfonamida de azolonas. | |
| MY107611A (en) | Isoxazole derivatives. | |
| MX9700339A (es) | Derivados de azolona anti-helcobacter que contienen urea y tiourea. | |
| ZA88309B (en) | 3(2h)pyridazinone,process for its preparation and antagonistic agent against srs-a containing it | |
| TW368501B (en) | 7-(2-aminoethyl)-benzothiazolones | |
| JPS5649378A (en) | Tetrazolylalkoxycarbostyril derivative | |
| DE69511260D1 (en) | Bicyclische amidinderivate als no-synthetase inhibitoren | |
| NO990335L (no) | Arylsykloalkankarboksylestere, anvendelse derav, farmas°ytiske sammensetninger og fremstilling | |
| IL67812A (en) | Indanylbenzamide derivatives,process for the preparation thereof and fungicidal compositions comprising the same | |
| ES8207180A1 (es) | Procedimiento de fabricacion de derivados de tetrahidro-5,67,7a 4h-tieno (3,2-c) piridinona-2 . | |
| ES8401067A1 (es) | Procedimiento analogo para preparar un derivado de tropil benzoato. | |
| MY108749A (en) | 3-deoxy-mannosamine derivatives and process for their preparation. | |
| ES2016017A6 (es) | Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico. | |
| NO934741L (no) | Fremgangsmåte for minimalisering og kontroll av ischemiske og reperfusjonsskade | |
| ES8305372A1 (es) | "procedimiento para la fabricacion de derivados de la tetrahidros -5,6,7,7a 4h-tieno (3,2-c)piridinona-2". | |
| ES8306161A1 (es) | Un procedimiento para la preparacion de nuevos derivados de nitrosourea. | |
| ES479110A1 (es) | Procedimiento para preparar derivados de benzamidina. | |
| ES446325A1 (es) | Procedimiento para preparar tieno-(3,2-c)-piridina y deriva-dos de la misma. | |
| ES8405409A1 (es) | Un procedimiento para la preparacion de derivados de b-lactama. | |
| ES454657A1 (es) | Procedimiento para preparar derivados de acidos 3,3'-tria- rilmetanodicarboxilicos. | |
| DE3271277D1 (en) | Tropyl and pseudotropyl alkyl-benzoates and their use in migraine treatment | |
| ES8505636A1 (es) | Procedimiento para preparar derivados de benzoato de propilo o pseudopropilo | |
| NZ239800A (en) | Substituted imidazole derivatives and medicaments | |
| DE3465737D1 (en) | Process for the preparation of 4-quinolinones |